Saturday 24 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
1
Average plausibility
74%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01ScienceAfrica

WHO announces Ebola vaccine trial in DR Congo

The trial will assess multiple vaccines, but the supplied report contains no design details or results.

Al Jazeera reports that WHO has announced the start of an Ebola vaccine clinical trial in the Democratic Republic of Congo. The trial is intended to test the safety, efficacy and immunogenicity of multiple vaccines.

What holds up

  • ✓The item explicitly attributes the trial-start announcement to WHO.
  • ✓The summary specifies multiple vaccines and three assessment objectives; it does not claim successful results.

What doesn't yet

  • ?No trial registration, protocol, enrollment figure or vaccine names are supplied.
  • ?The announcement is covered by only one provided outlet, with no direct WHO document available in the items.

Ask before you share

  • →Where is the registered protocol, and which vaccines and comparison groups are included?
  • →When will results be available, and what outcomes will determine efficacy?

Sources & original reporting

  1. [1]Al Jazeera · Published 24 Oct 2026 · aljazeera.com